Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04668001

Transcranial Photobiomodulation With Near-Infrared Light for Language in Individuals With Down Syndrome

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
19 (actual)
Sponsor
Massachusetts General Hospital · Academic / Other
Sex
All
Age
16 Years – 35 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to better understand the effects of transcranial photobiomodulation (tPBM) on neural oscillations of individuals diagnosed with Down syndrome.

Detailed description

This study will compare the effect of tPBM to sham tPBM on gamma neural oscillations in the brain as assessed by EEG, and on language, attention and memory as assessed by neuropsychological testing. Participants will be randomized to either tPBM with near-infrared light (tPBM-NIR) or tPBM-Sham and will undergo 18 treatments (3 treatments per week for 6 weeks) in addition to baseline, short-term and long- term follow up visits.

Conditions

Interventions

TypeNameDescription
DEVICENear-Infrared Transcranial PhotobiomodulationtPBM-NIR involves the use of a device that administers near-infrared light over the scalp. The light activates target brain regions.
DEVICESham Transcranial PhotobiomodulationtPBM-Sham involves the use of an identical device to tPBM-NIR but does not administer near-infrared light. It mimics the sensation by applying heat but does not actually activate target regions of the brain

Timeline

Start date
2021-10-19
Primary completion
2024-07-30
Completion
2024-09-01
First posted
2020-12-16
Last updated
2024-05-31

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04668001. Inclusion in this directory is not an endorsement.